AMYLYX PHARMACEUTICALS INC

NASDAQ: AMLX (Amylyx Pharmaceuticals, Inc.)

Last update: 05 Jan, 3:27PM

11.39

-0.03 (-0.26%)

  • 1D -0.26%
  • 5D -19.05%
  • 1M -7.62%
  • 6M 42.55%
  • YTD -0.26%
  • 1Y 226.36%
  • 5Y -36.97%
Previous Close 11.42
Open 11.37
Volume 2,052,723
Avg. Volume (3M) 1,566,329
Market Cap 1,250,844,928
Price / Sales 0.660
Price / Book 5.60
52 Weeks Range
2.60 (-77%) — 16.96 (48%)
Earnings Date 6 Nov 2025
Operating Margin (TTM) 16,317.06%
Diluted EPS (TTM) -3.10
Quarterly Revenue Growth (YOY) -99.60%
Total Debt/Equity (MRQ) 0.69%
Current Ratio (MRQ) 12.05
Operating Cash Flow (TTM) -206.98 M
Levered Free Cash Flow (TTM) -182.62 M
Return on Assets (TTM) -40.72%
Return on Equity (TTM) -83.24%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Bullish
Drug Manufacturers - Specialty & Generic (Global) Bullish Bullish
Stock Amylyx Pharmaceuticals, Inc. Bearish Bullish

AIStockmoo Score

0.3
Analyst Consensus -0.5
Insider Activity -3.5
Price Volatility -2.0
Technical Moving Averages 3.5
Technical Oscillators 4.0
Average 0.30

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
AMLX 1 B - - 5.60
LNTH 5 B - 27.55 3.98
KNSA 3 B - 93.91 5.58
HROW 2 B - - 35.03
BCRX 2 B - - 56.59
ALVO 1 B - 20.63 -

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Growth
% Held by Insiders 9.54%
% Held by Institutions 85.89%
52 Weeks Range
2.60 (-77%) — 16.96 (48%)
Median 20.00 (75.59%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 07 Nov 2025 20.00 (75.59%) Buy 12.31
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
COHEN JOSHUA B - 13.91 -138,167 -1,869,558
KLEE JUSTIN B. - 13.91 -138,188 -1,869,858
MILNE GEORGE M JR - 12.39 -17,780 -220,294
Aggregate Net Quantity -294,135
Aggregate Net Value ($) -3,959,710
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 13.61
Name Holder Date Type Quantity Price Value ($)
KLEE JUSTIN B. Officer 16 Jan 2026 Sell (-) 1,995 14.30 28,529
KLEE JUSTIN B. Officer 16 Jan 2026 Option execute 2,847 - -
COHEN JOSHUA B Officer 16 Jan 2026 Sell (-) 1,974 14.30 28,228
COHEN JOSHUA B Officer 16 Jan 2026 Option execute 2,818 - -
KLEE JUSTIN B. Officer 15 Jan 2026 Sell (-) 136,193 13.52 1,841,329
KLEE JUSTIN B. Officer 15 Jan 2026 Option execute 197,153 - -
COHEN JOSHUA B Officer 15 Jan 2026 Sell (-) 136,193 13.52 1,841,329
COHEN JOSHUA B Officer 15 Jan 2026 Option execute 197,182 - -
MILNE GEORGE M JR Director 12 Jan 2026 Disposed (-) 17,780 12.39 220,294

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria